Tehran University of Medical Sciences

Science Communicator Platform

Share By
Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients Publisher Pubmed

Summary: How can we quickly combat COVID-19? Review identifies promising broad-spectrum antiviral repurposing options targeting virus functions, a vital strategy for immediate response! #COVID19 #AntiviralDrugs

Ghanbari R1 ; Teimoori A2 ; Sadeghi A1 ; Mohamadkhani A1 ; Rezasoltani S3 ; Asadi E4 ; Jouyban A5 ; Sumner SCJ6
Authors

Source: Future Microbiology Published:2020


Abstract

COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing broad-spectrum antiviral drugs could be an effective strategy to respond immediately. In this review, a number of broad-spectrum antivirals with potential efficacy to inhibit the virus replication via targeting the virus spike protein (S protein), RNA-dependent RNA polymerase (RdRp), 3-chymotrypsin-like protease (3CLpro) and papain-like protease (PLpro) that are critical in the pathogenesis and life cycle of coronavirus, have been evaluated as possible treatment options against SARS-CoV-2 in COVID-19 patients. © 2021 Future Medicine Ltd
Related Docs
View other Related Docs
1. Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement, Biomedical and Biotechnology Research Journal (2020)
2. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)
3. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Azadeh Zarei (1)
Existing Antiviral Options Against Sars-Cov-2 Replication in Covid-19 Patients
Other Related Docs
4. Antiviral Optical Techniques As a Possible Novel Approach to Covid-19 Treatment*, (2024)
5. Therapeutic Strategies for Covid-19 Patients: An Update, Infectious Disorders - Drug Targets (2022)
6. Potential Role of Interferons in Treating Covid-19 Patients, International Immunopharmacology (2021)
7. Antiviral Therapy Inmanagement of Covid-19: A Systematic Review on Current Evidence, Archives of Academic Emergency Medicine (2020)
8. Covid-19 Immunotherapy: Treatment Based on the Immune Cell-Mediated Approaches, International Immunopharmacology (2022)
9. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
10. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
11. Binder Design for Targeting Sars-Cov-2 Spike Protein: An in Silico Perspective, Gene Reports (2022)
12. Tetracyclines As a Potential Antiviral Therapy Against Crimean Congo Hemorrhagic Fever Virus: Docking and Molecular Dynamic Studies, Computational Biology and Chemistry (2017)
13. Cinnamon and Its Possible Impact on Covid-19: The Viewpoint of Traditional and Conventional Medicine, Biomedicine and Pharmacotherapy (2021)
14. Photobiomodulation and Antiviral Photodynamic Therapy in Covid-19 Management, Advances in Experimental Medicine and Biology (2021)
15. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
16. Gallium Components-Based Drug Delivery: A Potential Treatment for Covid-19, Infectious Disorders - Drug Targets (2022)
17. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
18. A Review of Antibiotic Efficacy in Covid-19 Control, Journal of Immunology Research (2023)
19. Covid-19: General Strategies for Herbal Therapies, Journal of Evidence-Based Integrative Medicine (2022)
20. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)